Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Threshold’s cancer drug gets Orphan Drug designation
Threshold’s cancer drug gets Orphan Drug designation
Threshold’s cancer drug gets Orphan Drug designation
Submitted by
admin
on March 17, 2012 - 11:23am
Source:
Proactive Investors
News Tags:
Threshold Pharmaceuticals
TH-302
sarcoma
Headline:
Threshold’s cancer drug gets Orphan Drug designation
Do Not Allow Advertisers to Use My Personal information
